CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Opening Up Integration Module...

Veeva Systems To Accelerate the CRM of Life Science Businesses

Veeva Systems To Accelerate the CRM...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

The Future of Life Sciences Industry

The Future of Life Sciences Industry

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Accelerating Digital Transformation...

Re-imagining Learning in a Post-Pandemic World

Re-imagining Learning in a...

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Opening Up Integration Module...

Veeva Systems To Accelerate the CRM of Life Science Businesses

Veeva Systems To Accelerate the CRM...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

The Future of Life Sciences Industry

The Future of Life Sciences Industry

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Accelerating Digital Transformation...

Re-imagining Learning in a Post-Pandemic World

Re-imagining Learning in a...

Uplifting the Life-Science Sector Facilities Via Veeva Systems

Life Sciences Review | Wednesday, January 18, 2023
Tweet

Veeva Systems emerges as a leader in the life-science sector, owing to the seamless advantages it facilitates to businesses in the domain.                                        


FREMONT, CA: Veeva Systems has established an effective all-in-one software solution in the life sciences industry, favouring an efficient driving of product market growth for businesses, irrespective of their size, in addition to well-maintained compliance. The unique ecosystem of products enables drug developers to collect critical data and make decisions accordingly via a streamlined process expanding from research to commercialisation. Hence, with potential growth drivers in the arena, Veeva promises established and robust economic and revenue growth, allowing businesses to thrive exponentially in the sector.


For instance, drug developers may often encounter hindrances in meeting regulatory requirements and efficiently commercialising products. This is where Veeva comes to the rescue with two induced product solutions: Veeva Vault and Veeva Commercial Cloud. As a result, Veeva has most likely carved out a niche in the life sciences sector, enabling organisations in the field to achieve success and meet objectives effectively. As a potential software-as-a-service provider, Veeva specialises in a vast suite of offerings, targeting the life science industry with accelerated customer growth, with a customer base levelling up to nearly 22 per cent annually.


Surpassing a net retention rate of nearly 124 per cent in recent times, Veeva Vault facilitates a proven and robust success for organisations that are meticulously associated, accounting for drug developers’ tailored needs while bringing a drug to commercial markets. 


Hence, the approach assists drug developers throughout the development process, be it data management or safety assessment in the domain.


Customers, when adapting to the organisation’s Vault offerings, substantially realise the time savings on submission paperwork. That is, harnessing Veeva systems in the industry opens up seamless advantages like reducing time consumption while developing higher switching costs correspondingly. Therefore, the enterprise manages to stay on top of the competition table with intensified attention and response from customers.


Typically a growth leader in businesses, Vault is likely expanding at an average rate of 32 to 37 per cent in recent periods, surpassing the commercial cloud growth rate meticulously. Moreover, the product has considerably gained a share of subscription revenue in the current scenario, thereby accelerating its gross margin from time to time.


Alongside this, Veeva holds firm ground in lowering its operational expenses, enabling a robust operating income margin in the sector. Whence, soaring competitive advantages and an enforced financial discipline have critically enabled businesses to attain an elevated income value, which is anticipated to increase in future years accordingly.


Weekly Brief

loading
Top 10 Veeva Solutions Companies in Europe - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/uplifting-the-lifescience-sector-facilities-via-veeva-systems-nwid-1092.html